Plunkett Research Online: Aviragen Therapeutics Inc

AVIRAGEN THERAPEUTICS INC (AVIR) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Aviragen Therapeutics, Inc., formerly Biota Pharmaceuticals, Inc., formed from the merging of Nabi Biopharmaceuticals and Biota Holdings Ltd., is a development-level biopharmaceutical company that focuses on vaccines and therapies for the treatment and prevention of infectious diseases. The firm is.....


AVIRAGEN THERAPEUTICS INC

Ticker: AVIR
Exchange: NAS
Parent Company:
Employees:
Fiscal Year Ends in

Phone: 678-221-3343
Fax:
Address: 2500 Northwinds Pkwy., Ste. 100
Alpharetta, GA 30009 United States

Types Of Business
Industry Ranks

Industry NAICS code:

ContactsDescription

Mark ColonneseCFO/Chief Accounting Officer/Executive VP
Russell PlumbChairman of the Board/Director
See More
Aviragen Therapeutics, Inc., formerly Biota Pharmaceuticals, Inc., formed from the merging of Nabi Biopharmaceuticals and Biota Holdings Ltd., is a development-level biopharmaceutical company that focuses on vaccines and therapies for the treatment and prevention of infectious diseases. The firm is.....See More See More

$USD, In whole numbers 2017201620152014201320122011
Sales
Profits
Brands, Divisions and AffiliatesTop Salaries
Salary
Bonus
Other ThoughtsCorporate Culture